Natixis Advisors LLC Has $107.12 Million Position in Cardinal Health, Inc. $CAH

Natixis Advisors LLC increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 19.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 521,251 shares of the company’s stock after buying an additional 85,590 shares during the quarter. Natixis Advisors LLC owned 0.22% of Cardinal Health worth $107,117,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Versor Investments LP bought a new position in Cardinal Health during the third quarter valued at about $2,090,000. Machina Capital S.A.S. increased its stake in Cardinal Health by 248.0% during the third quarter. Machina Capital S.A.S. now owns 27,054 shares of the company’s stock valued at $4,246,000 after acquiring an additional 19,280 shares during the period. Nordea Investment Management AB increased its stake in Cardinal Health by 328.3% during the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock valued at $133,741,000 after acquiring an additional 494,731 shares during the period. Candriam S.C.A. increased its stake in Cardinal Health by 10.8% during the third quarter. Candriam S.C.A. now owns 196,163 shares of the company’s stock valued at $30,790,000 after acquiring an additional 19,155 shares during the period. Finally, Victory Capital Management Inc. increased its stake in Cardinal Health by 44.9% during the third quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after acquiring an additional 707,495 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Price Performance

Shares of CAH opened at $194.96 on Wednesday. The company has a market capitalization of $45.66 billion, a P/E ratio of 29.81, a PEG ratio of 1.16 and a beta of 0.52. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $233.60. The business’s 50 day simple moving average is $203.21 and its 200-day simple moving average is $208.75.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same period in the previous year, the business earned $2.35 EPS. Cardinal Health’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 1.1%. Cardinal Health’s dividend payout ratio is presently 31.19%.

Analyst Ratings Changes

CAH has been the topic of several research reports. Argus boosted their price target on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. UBS Group set a $260.00 price target on Cardinal Health and gave the company a “buy” rating in a research note on Friday, February 6th. Evercore decreased their price objective on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a report on Wednesday, April 8th. Mizuho lifted their price objective on Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a report on Friday, February 6th. Finally, Barclays lifted their price objective on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.